Review
Copyright ©The Author(s) 2022.
World J Gastroenterol. Jun 14, 2022; 28(22): 2417-2428
Published online Jun 14, 2022. doi: 10.3748/wjg.v28.i22.2417
Table 1 List of registered trials that use miRNAs as diagnostic and/or prognostic tool for hepatocellular carcinoma
Study title
Phase
Status
NCT number
MicroRNAs as diagnostic biomarkers in hepatocellular carcinoma among Somali patientsNAUnknownNCT03227510
Prospective cohort study of changes in circulatory microRNA of resected hepatocellular carcinomaNARecruitingNCT05148572
Clinical significance of hepatic and circulating microRNAs miR-221 and miR-222 in hepatocellular carcinomaNAUnknownNCT02928627
Study of microRNAs as a diagnostic tool for HCV-related hepatocellular carcinomaNAUnknownNCT03429530
Impact of IL-28B rs12979860 and rs4803217 gene polymorphisms associated with miRNAs deregulation on HCV-related hepatocellular carcinomaNAUnknownNCT02507882
MiRNA as a diagnostic and prognostic biomarker of hepatocellular carcinomaNANot yet recruitingNCT02448056
Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE)NARecruitingNCT04965259
Blood sample collection for experimental blood test to track liver cancerNARecruitingNCT04720430
Different genetic features associated with hepatic carcinogenesisNAUnknownNCT01247506
Genetic profiling of liver cancer in patients undergoing liver transplantationNAActive, not recruitingNCT02412579
A study of individualized radiotherapy based on a prediction model of lymph node metastasis in hepatocellular carcinomaNAUnknownNCT03416803
Fingerprint characterization of sorafenib treated HCCNAUnknownNCT03958669
Risk of HCC in cirrhotic patients post DAAs treatmentNAUnknownNCT03414554
Risk of hepatocellular carcinoma in patient with liver cirrhosisNAUnknownNCT03083002
Axitinib for the treatment of advanced hepatocellular carcinoma2CompletedNCT01210495
The phase III study of icaritin versus sorafenib in PD-L1 positive advanced hepatocellular carcinoma subjects3RecruitingNCT03236649
The phase III study of icaritin versus HUACHANSU PIAN in hepatocellular carcinoma subjects3RecruitingNCT03236636
A study of rSIFN-co in subjects with advanced solid tumors1CompletedNCT02387307
Stereotactic body radiation therapy and transarterial chemoembolization in treating patients with liver cancer that cannot be removed by surgery1CompletedNCT02507765
Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary-tract cancer2Active, not recruitingNCT03044587